Lisa J Wilmes Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

4/2007	AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
10/2005	Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa J Wilmes Research Topics

Disease

14	Breast Neoplasms (Breast Cancer) 09/2022 - 10/2005
9	Neoplasms (Cancer) 09/2022 - 10/2005
3	Pathologic Complete Response 09/2022 - 12/2019
1	Hyperoxia 12/2011
1	Necrosis 10/2005

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 11/2021 - 12/2019
2	human ERBB2 proteinIBA 01/2020 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2007
2	Phosphotransferases (Kinase)IBA 12/2007 - 04/2007
2	Tyrosine (L-Tyrosine)FDA Link 12/2007 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 12/2007 - 10/2005
2	Axitinib (AG 013736)IBA 04/2007 - 10/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007 - 10/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2007 - 10/2005
1	taxaneIBA 05/2013
1	hexafluorobenzeneIBA 12/2011
1	platinum oxideIBA 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	Growth Factor ReceptorsIBA 12/2007
1	Gefitinib (Iressa)FDA Link 12/2007
1	ErbB Receptors (EGF Receptor)IBA 12/2007

Therapy/Procedure

9	Neoadjuvant Therapy 01/2022 - 05/2013
6	Therapeutics 01/2020 - 10/2005
1	Immunotherapy 09/2022
1	Resuscitation 12/2011